Terms: = Kidney tumors AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
6 results:
1. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating smad4/SMAD7 signals.
Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
[TBL] [Abstract] [Full Text] [Related]
2. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
[TBL] [Abstract] [Full Text] [Related]
3. smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1.
Liu Y; Xu Y; Li X; Chen Z
Mol Med Rep; 2015 Apr; 11(4):2717-22. PubMed ID: 25482028
[TBL] [Abstract] [Full Text] [Related]
4. Secondary tumors of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a 10-year experience.
Waters L; Si Q; Caraway N; Mody D; Staerkel G; Sneige N
Diagn Cytopathol; 2014 Sep; 42(9):738-43. PubMed ID: 24554612
[TBL] [Abstract] [Full Text] [Related]
5. A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity.
Ji D; Deeds SL; Weinstein EJ
Oncol Rep; 2007 Dec; 18(6):1499-505. PubMed ID: 17982636
[TBL] [Abstract] [Full Text] [Related]
6. Renal parenchyma-sparing surgery as conservative treatment of renal cell carcinoma.
Ciancio G; Politano VA; Ferrell S; Block NL
Br J Urol; 1994 Oct; 74(4):422-30. PubMed ID: 7820417
[TBL] [Abstract] [Full Text] [Related]
